These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
85-1615012
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
N/A
|
|
(Former name, former address and former fiscal year, if changed since last report)
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
|
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant
|
SBG.U
|
New York Stock Exchange LLC
|
||
|
Shares of Class A common stock included as part of the units
|
SBG
|
New York Stock Exchange LLC
|
||
|
Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
|
SBG WS
|
New York Stock Exchange LLC
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
|
Non-accelerated filer
|
☒ |
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☒
|
|||
|
Page
|
||
|
PART 1 – FINANCIAL INFORMATION
|
||
|
Item 1.
|
1
|
|
|
1
|
||
|
2
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
Item 2.
|
14
|
|
|
Item 3.
|
16
|
|
|
Item 4.
|
16
|
|
|
PART II – OTHER INFORMATION
|
||
|
Item 1.
|
17
|
|
|
Item 1A.
|
17
|
|
|
Item 2.
|
17
|
|
|
Item 3.
|
17
|
|
|
Item 4.
|
17
|
|
|
Item 5.
|
17
|
|
|
Item 6.
|
17
|
|
|
19
|
||
|
ASSETS
|
||||
|
Current assets
|
||||
|
Cash
|
$
|
1,438,624
|
||
|
Prepaid expenses
|
302,955
|
|||
|
Total Current Assets
|
1,741,579
|
|||
|
Cash and marketable securities held in trust account
|
230,006,152
|
|||
|
Total Assets
|
$
|
231,747,731
|
||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||
|
Current liabilities
|
||||
|
Accrued expenses
|
$
|
16,667
|
||
|
Accrued offering costs
|
35,025
|
|||
|
Total Current Liabilities
|
51,692
|
|||
|
Deferred underwriting fee payable
|
8,050,000
|
|||
|
Total Liabilities
|
8,101,692
|
|||
|
Commitments and contingencies
|
||||
|
Class A common stock subject to possible redemption, 21,864,603 shares at $10.00 per share redemption value
|
218,646,030
|
|||
|
Stockholders’ Equity
|
||||
|
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
|
—
|
|||
|
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 1,135,397 shares issued and outstanding (excluding 21,864,603 shares subject to possible redemption)
|
114
|
|||
|
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding
|
575
|
|||
|
Additional paid-in capital
|
5,029,475
|
|||
|
Accumulated deficit
|
(30,155
|
)
|
||
|
Total Stockholders’ Equity
|
5,000,009
|
|||
|
Total Liabilities and Stockholders’ Equity
|
$
|
231,747,731
|
||
|
Three Months
Ended
September 30,
|
For the Period
from June 23,
2020
(Inception)
Through
September 30,
|
|||||||
|
2020
|
2020
|
|||||||
|
General and administrative expenses
|
$
|
36,307
|
$
|
36,307
|
||||
|
Loss from operations
|
(36,307
|
)
|
(36,307
|
)
|
||||
|
Other income:
|
||||||||
|
Interest earned on marketable securities held in trust account
|
6,152
|
6,152
|
||||||
|
Loss before provision for income taxes
|
(30,155
|
)
|
(30,155
|
)
|
||||
|
Provision for income taxes
|
—
|
—
|
||||||
|
Net loss
|
$
|
(30,155
|
)
|
$
|
(30,155
|
)
|
||
|
Weighted average shares outstanding of Class A redeemable common stock
|
23,000,000
|
23,000,000
|
||||||
|
Basic and diluted income per share, Class A
|
$
|
—
|
$
|
—
|
||||
|
Weighted average shares outstanding of Class B non-redeemable common stock
|
5,750,000
|
5,750,000
|
||||||
|
Basic and diluted net loss per share, Class B
|
$
|
(0.01
|
)
|
$
|
(0.01
|
)
|
||
|
Class A
Common Stock
|
Class B
Common Stock
|
Additional
Paid-in
|
Accumulated
|
Total
Stockholders’
|
||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Deficit
|
Equity
|
||||||||||||||||||||||
|
Balance – June 23, 2020 (Inception)
|
—
|
$
|
—
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||||||||||
|
Net loss
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
|
Balance – June 30, 2020
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||||
|
Issuance of Class B common stock to Sponsor
|
—
|
—
|
5,750,000
|
575
|
24,425
|
—
|
25,000
|
|||||||||||||||||||||
|
Sale of 23,000,000 Units, net of underwriting discounts
|
23,000,000
|
2,300
|
—
|
—
|
217,048,894
|
—
|
217,051,194
|
|||||||||||||||||||||
|
Sale of 6,600,000 Private Placement Warrants
|
—
|
—
|
—
|
—
|
6,600,000
|
—
|
6,600,000
|
|||||||||||||||||||||
|
Common stock subject to possible redemption
|
(21,864,603
|
)
|
(2,186
|
)
|
—
|
—
|
(218,643,844
|
)
|
—
|
(218,646,030
|
)
|
|||||||||||||||||
|
Net loss
|
—
|
—
|
—
|
—
|
—
|
(30,155
|
)
|
(30,155
|
)
|
|||||||||||||||||||
|
Balance – September 30, 2020
|
1,135,397
|
$
|
114
|
5,750,000
|
$
|
575
|
$
|
5,029,475
|
$
|
(30,155
|
)
|
$
|
5,000,009
|
|||||||||||||||
|
Cash Flows from Operating Activities:
|
||||
|
Net loss
|
$
|
(30,155
|
)
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||
|
Interest earned on marketable securities held in trust account
|
(6,152
|
)
|
||
|
Changes in operating assets and liabilities:
|
||||
|
Prepaid expenses
|
(302,955
|
)
|
||
|
Accrued expenses
|
16,667
|
|||
|
Net cash used in operating activities
|
(322,595
|
)
|
||
|
Cash Flows from Investing Activities:
|
||||
|
Investment of cash into Trust Account
|
(230,000,000
|
)
|
||
|
Net cash used in investing activities
|
(230,000,000
|
)
|
||
|
Cash Flows from Financing Activities:
|
||||
|
Proceeds from issuance of Class B common stock to Sponsor
|
25,000
|
|||
|
Proceeds from sale of Units, net of underwriting discounts paid
|
225,796,000
|
|||
|
Proceeds from sale of Private Placement Warrants
|
6,600,000
|
|||
|
Proceeds from promissory note—related party
|
250,000
|
|||
|
Repayment of promissory note – related party
|
(250,000
|
)
|
||
|
Payment of offering costs
|
(659,781
|
)
|
||
|
Net cash provided by financing activities
|
231,761,219
|
|||
|
Net Change in Cash
|
1,438,624
|
|||
|
Cash – Beginning of period
|
—
|
|||
|
Cash – End of period
|
$
|
1,438,624
|
||
|
Non-Cash financing activities:
|
||||
|
Initial classification of common stock subject to possible redemption
|
$
|
218,674,370
|
||
|
Change in value of common stock subject to possible redemption
|
$
|
(28,340
|
)
|
|
|
Deferred underwriting fee payable
|
$
|
8,050,000
|
||
|
Deferred offering costs included in accrued offering costs
|
$
|
35,025
|
||
|
•
|
in whole and not in part;
|
|
|
•
|
at a price of $0.01 per warrant;
|
|
|
•
|
upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and
|
|
|
•
|
if, and only if, the closing price of the Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three trading days before
the Company sends the notice of redemption to the warrant holders.
|
|
•
|
in whole and not in part;
|
|
|
•
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption
and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;
|
|
|
•
|
if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per share for any 20 trading days within the 30-trading day period ending three trading days
before the Company send the notice of redemption to the warrant holders; and
|
|
|
•
|
if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the
notice of redemption to the warrant holders is less than $18.00 per share, the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
|
|
|
Held-To-Maturity |
Amortized
Cost
|
Gross
Holding
Losses
|
Fair Value
|
|||||||||
|
September 30, 2020
|
U.S. Treasury Securities (Mature on 12/17/2020)
|
$
|
230,006,014
|
$
|
(6,023
|
)
|
$
|
229,999,991
|
|||||
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with
sufficient frequency and volume to provide pricing information on an ongoing basis.
|
|
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets
or liabilities in markets that are not active.
|
|
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
|
|
|
No.
|
Description of Exhibit
|
|
|
Underwriting Agreement, dated September 14, 2020, between the Company and Citigroup Global Markets Inc. and UBS Securities LLC, as representatives of the several underwriters
(1)
|
||
|
Amended and Restated Certificate of Incorporation
(1)
|
||
|
Warrant Agreement, dated September 14, 2020, between Continental Stock Transfer & Trust Company and the Company
(1)
|
||
|
Warrant Purchase Agreement, dated September 14, 2020, between the Company and Sandbridge Acquisition Holdings LLC
(1)
|
||
|
Investment Management Trust Account Agreement, dated September 14, 2020, between Continental Stock Transfer & Trust Company and the Company
(1)
|
||
|
Registration and Stockholder Rights Agreement, dated September 14, 2020, among the Company, the Sponsor and the other Holders (as defined therein) signatory thereto
(1)
|
||
|
Letter Agreement, dated September 14, 2020, among the Company, the Sponsor, certain investors in the Sponsor and each of the initial stockholders, directors and officers of the Company
(1)
|
||
|
Administrative Services Agreement, dated September 14, 2020, between the Company and Sandbridge Capital, LLC
(1)
|
||
|
Form of Indemnification Agreement, dated September 14, 2020, between the Company and each of the officers and directors of the Company
(1)
|
||
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
101.INS*
|
XBRL Instance Document
|
|
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB*
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
*
|
Filed herewith.
|
|
**
|
Furnished herewith.
|
|
(1)
|
Previously filed as an exhibit to our Current Report on Form 8-K filed on September 18, 2020 and incorporated by reference herein.
|
|
SANDBRIDGE ACQUISITION CORPORATION
|
||
|
Date: November 13, 2020
|
By:
|
/s/ Ken Suslow
|
|
Name:
|
Ken Suslow
|
|
|
Title:
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|
||
|
Date: November 13, 2020
|
By:
|
/s/ Richard Henry
|
|
Name:
|
Richard Henry
|
|
|
Title:
|
Chief Financial Officer
|
|
|
(Principal Accounting and Financial Officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|